Abiopharma

🔍 Friedman Douglas (Executive)

Company: Tradeweb Markets Inc. (TW)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Sold 619 shares of Class A common stock at $126.17 per share (Direct)
  Date: 2026-03-17 | Code: F | equity_swap_involved: 0 | shares_owned_after: 16,731.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 1 shares of Class A common stock (Direct)
  Date: 2026-03-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,732.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: Represents shares withheld by the issuer to satisfy the tax withholding obligation associated with the settlement of restricted stock units ("RSUs") in respect of the issuer's Class A common stock ("Class A Common Stock") held by the reporting person.
• F2: This amount includes (i) 1,990 unvested RSUs in respect of Class A Common Stock that are scheduled to vest on March 15, 2027, (ii) 2,421 unvested RSUs in respect of Class A Common Stock that are scheduled to vest in equal installments on March 17, 2027 and March 17, 2028 and (iii) 6,510 unvested RSUs in respect of Class A Common Stock that are scheduled to vest on March 15, 2027, March 15, 2028 and March 15, 2029, in each case, subject to the reporting person's continued employment through the applicable vesting date.
• F3: Represents shares of Class A Common Stock acquired in connection with the settlement of certain dividend equivalent rights (the "DERs"). The DERs were granted in connection with previously awarded RSUs, and settled in shares of Class A Common Stock in connection with the settlement of the RSUs to which they relate.